Bolt Biotherapeutics
BOLT | NASDAQ
$5.80
-$0.28 (-4.61%)
At close: Nov 16, 2026, 4:00 PM ET
$5.80
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:15 PM ET
-4.61%
(1D)No price chart data available for 1D timeframe.
Rating
29.8
+3.0 ptsFundamentals Weak
Market Sentiment Bullish
Moat None
Sector Rank #797/1021 (Top 78%)
Key Statistics
Market Data
Market Cap $11.17M
1D Range
5.61 6.05
52W Range
3.18 7.09
Valuation (TTM)
PE -0.40
PB 1.30
EV/EBITDA -0.68
Valuation (NTM)
Forward PE N/A
Forward PEG 0.03
Price Target $4.00
Cash Flow
FCF Yield -222.1%
SBC Adj. FCF Yield -245.7%
SBC Impact -10.7%
Margins
Gross Margin 92.0%
Operating Margin -1039.5%
FCF Margin -980.2%
Growth (CAGR)
Revenue 3Y | 5Y -29.4% |
27.5%
Dil EPS 3Y | 5Y -76.5% |
-52.6%
FCF 3Y | 5Y 41.0% |
23.5%
Returns
ROA -73.1%
ROE -154.1%
ROIC -86.2%
Financial Health
Net Cash
$14.8M
Current Ratio 2.05
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the b...
Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date Feb 5, 2021
Website www.boltbio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$2.25
Beat +38.86%
YoY:
+39.52% REV
$450K
Beat 0.00%
YoY:
-79.25%Next Earnings
Mar 11, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$4.00
Downside
-31.03%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BOLT